Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
71 0% |
 |
Gilead SciencesGILD |
54 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Sep 2025 | 32 | |
| Aug 2025 | 33 | |
| Jul 2025 | 33 | |
| Jun 2025 | 34 | |
| May 2025 | 38 |
How do employees feel about the future at Biomarin Pharmaceutical?
According to employees, the Business Outlook at Biomarin Pharmaceutical is highly negative. This is reflected in the average rating of 32 out of 100, which is considered very low.
Analyzing Business Outlook, how is Biomarin Pharmaceutical performing compared to its industry peers?
Biomarin Pharmaceutical underperforms its industry peers when it comes to Business Outlook, ranking in the 32nd percentile.
How has the business outlook at Biomarin Pharmaceutical changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Biomarin Pharmaceutical.
Why is it important to track the business outlook at Biomarin Pharmaceutical?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Biomarin Pharmaceutical.
